Tag: GNBT

  • Drug Delivery: Generex Biotechnology (NASDAQ:GNBT), Valeant Pharmaceuticals International NYSE:VRX), Flamel Technologies SA (NASDAQ:FLML), PetMed Express (NASDAQ:PETS)

    Generex Biotechnology Corp. (NASADQ:GNBT) stock volume soared Mar. 11, with 9,325,106 shares changing hands, significantly higher than its three-month average volume of 7,012,285 shares. Generex Biotechnology Corp. (NASDAQ:GNBT) shares after opening at $0.05 moved to $0.05 on last trade day and at the end of the day closed at $0.04. Company price to sales ratio in past twelve months was calculated as 9.59 and price to cash ratio as 0.81. Generex Biotechnology Corp. (NASADQ:GNBT) showed a positive weekly performance of 3.50%.

    A litigation settlement with Valeant Pharmaceuticals International Inc. (NYSE:VRX) provided the main boost to its bottom line. In October, Valeant Pharmaceuticals International Inc. (NYSE:VRX) agreed to pay $142.5 million to Anacor to resolve all outstanding disputes between the two companies. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) shares advanced 0.64% in last trading session and ended the day on $140.90. VRX return on equity ratio is recorded as -24.00% and its return on assets is -5.20%. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) yearly performance is 101.69%.

    Flamel Technologies SA (NASDAQ:FLML) has collaborations with a number of leading pharmaceutical and biotechnology companies, including GlaxoSmithKline (Coreg CR®, carvedilol phosphate). The Company is headquartered in Lyon, France and has operations in St. Louis, Missouri, USA, and manufacturing facilities in Pessac, France. Flamel Technologies SA (NASDAQ:FLML) shares moved up 4.90% in last trading session and was closed at $11.14, while trading in range of $10.58 – $11.22. Flamel Technologies SA (NASDAQ:FLML) year to date (YTD) performance is 38.39%.

    PetMed Express, Inc. (NASDAQ:PETS) experiences a ratings drop this week, going from last week’s C to a D. PetMed Express Inc. (NASDAQ:PETS) weekly performance is -5.69%. On last trading day company shares ended up $13.25. PetMed Express Inc. (NASDAQ:PETS) distance from 50-day simple moving average (SMA50) is -4.72%. Analysts mean target price for the company is $15.40.